PALM BEACH GARDENS, Fla., Jan. 10 /PRNewswire-FirstCall/ -- MediSys Corporation announced today that it has named Dr. Garry Goldstein, former Medical Director for General Motors, to a position on the Company's Advisory Board. Dr. Goldstein and the rest of the Advisory Board will oversee both internal and external affairs for the Company, including the ongoing development of the MediSys "MaxLife Center for Men(TM)" program, and the various community-based activities that are planned to help build awareness for the Company.
Dr. Goldstein, a former research fellow for Harvard University, received his medical degree from the University of Virginia and performed his post doctoral work at MIT. For 12 years of his esteemed career he served as a Medical Director for General Motors Corporation. Dr. Goldstein has also been a medical consultant for the Aetna and Metropolitan Life Insurance Companies.
In addition to owning and operating his own successful private practice, specializing in Internal Medicine, for 22 years, Dr. Goldstein has also served as a past president of the Delaware component and a member of the House of Delegates of the American College of Occupational & Environmental Medicine, and as a regional Medical Examiner for United Parcel Service (UPS). Dr. Goldstein is certified by the American Board of Forensic Medicine and is Board Eligible in three specialties: Internal Medicine; Preventative Medicine; and Emergency Medicine.
Dr. Goldstein was quoted as saying, "With 22 years in private practice in Internal Medicine and 22 years of teaching medicine at Boston University I can say that this is a very important project to put forward to the Internists for diagnosing and early prevention of other disease states such as Diabetes's and Heart Disease."
MediSys Corporation's Medical Director, Dr. Ralph C. Benson had this to say, "Dr. Goldstein has extensive experience and realizes the importance preventative medicine has as it relates to men's health. He brings decades of experience in dealing with industry and the importance of proactive approaches to health care and is an advocate for the fact that wellness works for the patient and society."
MediSys CEO Joshua Konigsberg commented, "Dr. Goldstein is a tremendous addition to the MediSys Advisory Board. His education, credentials and extensive experience as acting medical examiner as well as medical director for various industries, including the insurance industry, coupled with his 22 years experience in private practice, are very relevant to the Company's mission and goals in bringing useful practice enhancement tools to the Internal and Family Medicine markets. We are grateful to have him as a valued member of the team."
More information on Dr. Goldstein can be found on the Company's corporate Web site: http://www.medisyscorp.com/ .
MediSys' proprietary disease identification and management system for men (The MaxLife Center for Men(TM)) enables physicians to make the best decisions in terms of diagnosis and treatment for a large number of serious diseases prevalent in men. Working with nationally acclaimed medical doctors, the Management Team discovered that many serious and sometimes life-threatening diseases prevalent in men often share common underlying symptoms. The MaxLife Center for Men is marketed to internal medicine, family medicine and cardiology markets and enables doctors to provide superior medical & treatment plans while significantly improving their practice revenues.
Disclaimer Regarding Forward-Looking Statements:
This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.
Contact: Brian Gibson
800 Village Square Crossing
Palm Beach Gardens, FL 33410